Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor
Takumi Kumai(Asahikawa Medical University), Hiroya Kobayashi(Asahikawa Medical College Hospital)
Cited by 31
Related Papers
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
|Journal of Translational Medicine|2019|18
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapy
|Cancer Immunology Immunotherapy|2023|7